![James Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Sullivan
Technik-/Wissenschafts-/F&E-Leiter bei
enGene, Inc.
Profil
James C.
Sullivan is currently the Chief Scientific Officer at enGene, Inc. He previously held positions as the Executive Director & Head-Translational Biology at Sana Biotechnology, Inc., and as the Senior Vice President-Pulmonary Discovery at Translate Bio, Inc. He also served as the Chief Scientific Officer at enGene Holdings, Inc. Dr. Sullivan obtained a doctorate degree from Boston University, an undergraduate degree from Boston College, and a graduate degree from University College Dublin.
Aktive Positionen von James Sullivan
| Unternehmen | Position | Beginn |
|---|---|---|
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2022 |
Ehemalige bekannte Positionen von James Sullivan
| Unternehmen | Position | Ende |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 21.10.2024 |
| TRANSLATE BIO, INC. | Corporate Officer/Principal | 01.02.2022 |
| SANA BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 01.01.2021 |
Ausbildung von James Sullivan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
 University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
